Vaccinating against monkeypox in the Democratic Republic of the Congo

Bass, 2013, Enhancing healthcare worker ability to detect and care for patients with monkeypox in the Democratic Republic of the Congo, Int. Health, 5, 237, 10.1093/inthealth/iht029

Bray, 2003, Progressive vaccinia, Clin. Infect. Dis., 36, 766, 10.1086/374244

Burns, 2012, Licensure of vaccines using the animal rule, Curr. Opin. Virol., 2, 353, 10.1016/j.coviro.2012.01.004

Durski, 2018, Emergence of monkeypox - West and Central Africa, 1970-2017, MMWR Morb. Mortal. Wkly. Rep., 67, 306, 10.15585/mmwr.mm6710a5

Earl, 2008, Rapid protection in a monkeypox model by a single injection of a replication-deficient vaccinia virus, Proc. Natl. Acad. Sci. U. S. A., 105, 10889, 10.1073/pnas.0804985105

Frey, 2007, Clinical and immunologic responses to multiple doses of IMVAMUNE (Modified Vaccinia Ankara) followed by Dryvax challenge, Vaccine, 25, 8562, 10.1016/j.vaccine.2007.10.017

Frey, 2013, Safety and immunogenicity of IMVAMUNE(R) smallpox vaccine using different strategies for a post event scenario, Vaccine, 31, 3025, 10.1016/j.vaccine.2013.04.050

Frey, 2015, Comparison of lyophilized versus liquid modified vaccinia Ankara (MVA) formulations and subcutaneous versus intradermal routes of administration in healthy vaccinia-naive subjects, Vaccine, 33, 5225, 10.1016/j.vaccine.2015.06.075

Greenberg, 2013, Safety, immunogenicity, and surrogate markers of clinical efficacy for modified vaccinia Ankara as a smallpox vaccine in HIV-infected subjects, J. Infect. Dis., 207, 749, 10.1093/infdis/jis753

Hoff, 2017, Varicella coinfection in patients with active monkeypox in the democratic Republic of the Congo, EcoHealth, 14, 564, 10.1007/s10393-017-1266-5

Jezek, 1988, Human monkeypox: secondary attack rates, Bull. World Health Organ., 66, 465

Keckler, 2011, Establishment of the black-tailed prairie dog (Cynomys ludovicianus) as a novel animal model for comparing smallpox vaccines administered preexposure in both high- and low-dose monkeypox virus challenges, J. Virol., 85, 7683, 10.1128/JVI.02174-10

Ladnyj, 1972, A human infection caused by monkeypox virus in Basankusu Territory, Democratic Republic of the Congo, Bull. World Health Organ., 46, 593

Lane, 1970, Complications of smallpox vaccination, 1968: results of ten statewide surveys, J. Infect. Dis., 122, 303, 10.1093/infdis/122.4.303

Lane, 1969, Complications of smallpox vaccination, 1968, N. Engl. J. Med., 281, 1201, 10.1056/NEJM196911272812201

McCollum, 2014, Human monkeypox, Clin. Infect. Dis., 58, 260, 10.1093/cid/cit703

Mora, 2009, Cardiac complications after smallpox vaccination, South Med. J., 102, 615, 10.1097/SMJ.0b013e31819fe55b

Morgan, 2008, Myocarditis, pericarditis, and dilated cardiomyopathy after smallpox vaccination among civilians in the United States, January-October 2003, Clin. Infect. Dis., 46, S242, 10.1086/524747

Nakazawa, 2013, Mapping monkeypox transmission risk through time and space in the Congo Basin, PloS One, 8, 10.1371/journal.pone.0074816

Norheim, 2015, Avoiding 40% of the premature deaths in each country, 2010-30: review of national mortality trends to help quantify the UN sustainable development goal for health, Lancet, 385, 239, 10.1016/S0140-6736(14)61591-9

Petersen, 2015, Clinical guidance for smallpox vaccine use in a postevent vaccination program, MMWR Recomm. Rep., 64, 1

Petersen, 2015, Use of vaccinia virus smallpox vaccine in laboratory and healthcare personnel at risk for occupational exposure to orthopoxviruses - recommendations of the advisory committee on immunization practices (ACIP), MMWR Morb. Mortal. Wkly. Rep. 2016, 65, 257, 10.15585/mmwr.mm6510a2

Reed, 2004, The detection of monkeypox in humans in the Western Hemisphere, N. Engl. J. Med., 350, 342, 10.1056/NEJMoa032299

Reed, 2012, Eczema vaccinatum, Clin. Infect. Dis., 54, 832, 10.1093/cid/cir952

Rimoin, 2011, Whither monkeypox vaccination, Vaccine, 29, D60, 10.1016/j.vaccine.2011.09.004

Rimoin, 2010, Major increase in human monkeypox incidence 30 years after smallpox vaccination campaigns cease in the Democratic Republic of Congo, Proc. Natl. Acad. Sci. U. S. A, 107, 16262, 10.1073/pnas.1005769107

Ryan, 2008, Vaccine in Pregnancy Registry, Pregnancy, birth, and infant health outcomes from the National Smallpox Vaccine in Pregnancy Registry, 2003-2006, Clin. Infect. Dis., 46, S221, 10.1086/524744

Shiferaw, 2017, Frameworks for preventing, detecting, and Controlling zoonotic diseases, Emerg. Infect. Dis., 23, 10.3201/eid2313.170601

Stittelaar, 2005, Modified vaccinia virus Ankara protects macaques against respiratory challenge with monkeypox virus, J. Virol., 79, 7845, 10.1128/JVI.79.12.7845-7851.2005

Vollmar, 2006, Safety and immunogenicity of IMVAMUNE, a promising candidate as a third generation smallpox vaccine, Vaccine, 24, 2065, 10.1016/j.vaccine.2005.11.022

von, 2010, A randomized, double-blind, dose-finding Phase II study to evaluate immunogenicity and safety of the third generation smallpox vaccine candidate IMVAMUNE, Vaccine, 28, 1209, 10.1016/j.vaccine.2009.11.030

Walsh, 2013, Safety and immunogenicity of modified vaccinia Ankara in hematopoietic stem cell transplant recipients: a randomized, controlled trial, J. Infect. Dis., 207, 1888, 10.1093/infdis/jit105